SCHEMBL289943

SCHEMBL289943

COC(=O)NS(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8137367 0.77
SCHEMBL529835 0.75 GAA (0.42)
SCHEMBL11864816 0.75 HTT (0.39)
SCHEMBL8137370 0.74
SCHEMBL5639498 0.74
SCHEMBL21125610 0.74 CA12 (0.36)
SCHEMBL7611491 0.72
SCHEMBL29098391 0.72 CA2 (0.38)
SCHEMBL25962018 0.72 CA14 (0.37)
SCHEMBL13824717 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010861-A Buronate clamp Process for the preparation of a medicament 杭州科巢生物科技有限公司 2026-05-12 CN disclosed
WO-2023149556-A1 NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE BATTERY, NON-AQUEOUS ELECTROLYTE BATTERY PRODUCTION METHOD, COMPOUND, AND ADDITIVE FOR NON-AQUEOUS ELECTROLYTE セントラル硝子株式会社 2023-08-10 WO disclosed
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST PHARM CO., LTD. (KR) 2022-07-28 US disclosed
EP-3978480-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST Pharm Co., Ltd. (KR) 2022-04-06 EP disclosed
EP-2683698-B1 BENZYL-OXATHIAZINE DERIVATES SUBSTITUTED WITH ADAMANTANE OR NORADAMANTANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND USE THEREOF SANOFI SA (FR) 2017-10-04 EP disclosed
EP-2740723-B1 SULPHAMIDE DERIVATIVE HAVING AN ADAMANTYL GROUP AND A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KOREA RES INST CHEMICAL TECH (KR) 2017-05-10 EP disclosed
US-9505761-B2 Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2016-11-29 US disclosed
US-20160297817-A1 BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS FEDORA PHARMACEUTICALS INC. (CA) 2016-10-13 US disclosed
US-9393239-B2 Bicyclic compounds and their use as antibacterial agents and betalactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2016-07-19 US disclosed
US-9073906-B2 Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2015-07-07 US disclosed
US-7902181-B2 Compounds 010 ASTRAZENECA AB (SE) 2011-03-08 US disclosed
WO-2010128324-A1 SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750 ASTRAZENECA AB (SE) 2010-11-11 WO disclosed
US-20100286118-A1 SUBSTITUTED 1-CYANOETHYLHETEROCYCLYLCARBOXAMIDE COMPOUNDS 750 ASTRAZENECA AB (SE) 2010-11-11 US disclosed
EP-2231597-A1 PEPTIDYL NITRILES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE I INHIBITORS AstraZeneca AB (SE) 2010-09-29 EP disclosed
US-20090306042-A1 Novel Compounds 010 ASTRAZENECA AB (SE) 2009-12-10 US disclosed
WO-2009074829-A1 PEPTIDYL NITRILES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE I INHIBITORS ASTRAZENECA AB (SE) 2009-06-18 WO disclosed
EP-0592439-B1 AMINOSULFONYL CARBAMATES WARNER LAMBERT CO (US) 2003-07-30 EP disclosed
WO-1996002530-A1 PIPERIDINES AND HEXAHYDRO-1H-AZEPINES SPIRO SUBSTITUTED AT THE 4-POSITION PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1996-02-01 WO disclosed
US-5254715-A Anticholesterol agents WARNER-LAMBERT COMPANY (US) 1993-10-19 US disclosed
US-3996208-A PENICILLINS CIBA-GEIGY CORPORATION (US) 1976-12-07 US disclosed